CPT code 52441 describes the cystourethroscopic placement of a single permanent adjustable transprostatic implant to retract prostatic lobes that obstruct the urethra. This code captures a targeted, minimally invasive surgical approach to relieve urinary outflow obstruction due to prostatic enlargement and is increasingly relevant as implant and office-based urologic technologies evolve. Nationally, the code matters for procedure classification, payment policy, and care pathway standardization for men with symptomatic prostatic obstruction.

Key payers in the analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of what CPT code 52441 represents, the typical clinical setting and service type, and the expected areas of review for payers and policy teams. The publication outlines benchmarks and reimbursement context, highlights relevant clinical indications and coding considerations, and summarizes recent policy developments affecting coverage and site-of-service decisions.

The content is intended for coding professionals, urology clinical leaders, and payer policy analysts seeking a clear national summary of the code, its clinical role, and the policy and billing topics stakeholders commonly evaluate.